You are here: Industry Insights > lupin

News List

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US expresspharma
July 27, 2020
Various companies across the globe have announced similar recalls for the product after the USFDA pointed out the presence of NDMA above permissible limits.
Lupin receives US FDA’s tentative approval for Empagliflozin and Linagliptin Tablets expresspharma
July 24, 2020
Empagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Over 158 applications for generic products pending with US FDA for approval: Lupin expresspharma
July 22, 2020
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir.
Lupin recalls diabetes treatment drug in US expresspharma
July 13, 2020
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.
Indian pharma firms recall medications from US market expresspharma
July 06, 2020
Lupin and Marksans Pharma recall diabetes drugs while Alembic and Aurbindo recall medicines that treat mental disorders.
Unichem, Lupin voluntarily recall hypertension medicines in the US expresspharma
June 22, 2020
Unichem is recalling 1,90,992 bottles of Clonodine Hydrochloride tablets while Lupin is recalling 4,224 bottles of Lisinopril tablets.
Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US expresspharma
June 16, 2020
Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs ...
Lupin voluntarily recalls a lot of diabetes drug in the US expresspharma
June 16, 2020
An FDA analysis showed that this lot exceeded the acceptable daily intake limit for NDMA, an impurity that can cause cancer.
Lupin ties up with Omron Healthcare expresspharma
June 15, 2020
Medical device maker Omron Healthcare India has joined hands with pharma firm Lupin to strengthen respiratory disease management facilities, focussing on asthma and chronic obstructive pulmonary disease patients.
Lupin to approach USFDA for reinspection of key plants in next few months expresspharma
June 15, 2020
Reportedly, regulatory action by the USFDA has impacted several new approvals, thus affecting the company's business in various regions including the US that remains the single-largest pharma market globally.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page